Eur Rev Med Pharmacol Sci 2021; 25 (2): 731-737
DOI: 10.26355/eurrev_202101_24634

FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells

X.-H. Liu, L.-P. Liu, X.-M. Xu, M. Hua, Q. Kang, A. Li, L. Huang

Department of Oncology, Department of Hematology; The First Affiliated Hospital of Gannan Medical University, Ganzhou, China. hlellen@gmu.edu.cn


OBJECTIVE: The aim of this study was to explore the roles of FOXN2 (Fork head Box N2) in mediating the proliferation and invasion of hepatocellular carcinoma (HCC) cells.

PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was used to determine expression of FOXN2 in HCC tissues and cells. Transfection of plasmid containing FOXN2 was used to exogenously overexpress FOXN2 in vitro. Cell Counting Kit-8 (CCK-8) assay and transwell assay were applied to detect the proliferation and invasion of HCC cells, respectively.

RESULTS: FOXN2 expression decreased significantly in both HCC tissues and cells (p<0.05). Upregulation of FOXN2 significantly inhibited the proliferation and invasion of HCC cells (p<0.05).

CONCLUSIONS: FOXN2 acts as a regulator in the progression of HCC. Our findings suggest that FOXN2 may be a novel therapeutic monitoring and prognosis biomarker in HCC.

Free PDF Download

To cite this article

X.-H. Liu, L.-P. Liu, X.-M. Xu, M. Hua, Q. Kang, A. Li, L. Huang
FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 2
Pages: 731-737
DOI: 10.26355/eurrev_202101_24634